TEVA logo

TEVA Operating Expenses

Latest reported$7.10B
TEVA TTM Operating Expenses (-$79.30M → $7.10B)
High-resolution chart · PNG

TEVA operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
7,099,000,000
6,742,000,000
6,782,000,000
6,576,000,000
7,353,000,000
7,735,000,000
8,366,000,000
7,877,000,000
7,185,000,000
7,606,000,000
7,212,000,000
8,177,000,000
7,920,000,000
8,213,000,000
9,071,000,000
8,418,000,000
8,339,000,000
6,887,000,000
5,878,000,000
5,548,000,000
10,571,000,000
10,870,000,000
11,298,000,000
11,465,000,000
6,391,000,000
6,039,000,000
5,368,000,000
4,995,000,000
5,238,000,000
5,316,000,000
5,532,000,000
5,813,000,000
6,185,000,000
6,587,000,000
6,834,000,000
7,241,000,000
7,419,000,000
7,339,000,000
7,207,000,000
6,736,000,000
6,280,000,000
6,213,000,000
6,242,000,000
6,294,000,000
6,492,000,000
6,488,000,000
6,566,000,000
6,720,000,000
6,681,000,000
6,754,000,000
6,746,000,000
6,703,000,000
6,617,000,000
6,572,000,000
6,473,000,000
6,394,000,000
6,009,000,000
6,017,000,000
5,777,000,000
5,389,000,000
5,470,000,000
4,917,000,000
4,770,000,000
4,610,000,000
4,462,000,000
4,479,000,000
4,353,000,000
5,461,000,000
5,225,000,000
5,025,000,000
4,699,000,000
3,088,000,000
2,845,000,000
2,584,000,000
2,482,000,000
2,475,800,000
2,414,900,000
2,305,000,000
2,132,400,000
1,767,900,000
1,536,200,000
1,313,300,000
1,167,700,000
1,133,000,000
1,098,500,000
1,081,500,000
1,064,900,000
990,800,000
899,000,000
721,200,000
634,100,000
584,200,000
553,100,000
610,200,000
571,400,000
542,937,000
500,637,000
483,032,000
470,791,000
467,375,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.